Overall survival after progression in patients with uterine carcinosarcoma: a single-center retrospective cohort study.

ABSTRACT:

Objective

To investigate 2-year overall survival (OS) after progression in patients with uterine carcinosarcoma (UCS).

Methods

This retrospective descriptive cohort study included patients diagnosed with progressive UCS at all stages, who underwent surgical staging with or without adjuvant therapy between January 2002 and December 2022. Clinicopathological characteristics, including recurrence patterns, were assessed using descriptive statistics, Fisher's exact test, and the chi-squared test. Prognostic factors and OS after progression were analyzed using the Cox proportional hazards model and Kaplan-Meier method, respectively.

Results

Fifty-four patients (mean age, 61 years) were eligible for analysis. During primary treatment, 40 patients underwent optimal surgery,

SUBMITTER: Buhachat R 

PROVIDER: S-EPMC12301562 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature